StonvexLoading…
StonvexStonvexStonvexCore line items from NTNX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 (Est.) Expected 2026-05-27 | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Annual 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|---|
Revenue | $700.10M | $1.39B | $670.58M | $2.54B | $1.88B |
Operating Income | Not available | $133.47M | $49.34M | $172.54M | $141.33M |
Net Income | Not available | $165.12M | $62.10M | $188.37M | $149.72M |
EPS (Diluted) | $0.36 | $0.57 | $0.21 | $0.65 | $0.52 |
Total Assets | Not available | $3.28B | $3.32B | $3.28B | $3.10B |
Total Liabilities | Not available | $4.11B | $3.99B | $3.98B | $3.81B |
Cash & Equivalents | Not available | $603.40M | $780.42M | $769.50M | $872.60M |
Free Cash Flow OCF − CapEx | Not available | $365.92M | $174.51M | $750.17M | $542.39M |
Shares Outstanding | Not available | 294.21K | 296.52K | 294.08K | 292.94K |